First Time Loading...

Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 41.6 EUR -0.48% Market Closed
Updated: Apr 18, 2024

Intrinsic Value

Biotest AG is a DE-based company operating in Biotechnology industry. [ Read More ]

The intrinsic value of one BIO stock under the Base Case scenario is 36.5 EUR. Compared to the current market price of 41.6 EUR, Biotest AG is Overvalued by 12%.

Key Points:
BIO Intrinsic Value
Base Case
36.5 EUR
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biotest AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BIO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biotest AG

Provide an overview of the primary business activities
of Biotest AG.

What unique competitive advantages
does Biotest AG hold over its rivals?

What risks and challenges
does Biotest AG face in the near future?

Summarize the latest earnings call
of Biotest AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biotest AG.

Provide P/S
for Biotest AG.

Provide P/E
for Biotest AG.

Provide P/OCF
for Biotest AG.

Provide P/FCFE
for Biotest AG.

Provide P/B
for Biotest AG.

Provide EV/S
for Biotest AG.

Provide EV/GP
for Biotest AG.

Provide EV/EBITDA
for Biotest AG.

Provide EV/EBIT
for Biotest AG.

Provide EV/OCF
for Biotest AG.

Provide EV/FCFF
for Biotest AG.

Provide EV/IC
for Biotest AG.

Show me price targets
for Biotest AG made by professional analysts.

What are the Revenue projections
for Biotest AG?

How accurate were the past Revenue estimates
for Biotest AG?

What are the Net Income projections
for Biotest AG?

How accurate were the past Net Income estimates
for Biotest AG?

What are the EPS projections
for Biotest AG?

How accurate were the past EPS estimates
for Biotest AG?

What are the EBIT projections
for Biotest AG?

How accurate were the past EBIT estimates
for Biotest AG?

Compare the revenue forecasts
for Biotest AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biotest AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biotest AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biotest AG compared to its peers.

Compare the P/E ratios
of Biotest AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Biotest AG with its peers.

Analyze the financial leverage
of Biotest AG compared to its main competitors.

Show all profitability ratios
for Biotest AG.

Provide ROE
for Biotest AG.

Provide ROA
for Biotest AG.

Provide ROIC
for Biotest AG.

Provide ROCE
for Biotest AG.

Provide Gross Margin
for Biotest AG.

Provide Operating Margin
for Biotest AG.

Provide Net Margin
for Biotest AG.

Provide FCF Margin
for Biotest AG.

Show all solvency ratios
for Biotest AG.

Provide D/E Ratio
for Biotest AG.

Provide D/A Ratio
for Biotest AG.

Provide Interest Coverage Ratio
for Biotest AG.

Provide Altman Z-Score Ratio
for Biotest AG.

Provide Quick Ratio
for Biotest AG.

Provide Current Ratio
for Biotest AG.

Provide Cash Ratio
for Biotest AG.

What is the historical Revenue growth
over the last 5 years for Biotest AG?

What is the historical Net Income growth
over the last 5 years for Biotest AG?

What is the current Free Cash Flow
of Biotest AG?

Financials

Balance Sheet Decomposition
Biotest AG

Current Assets 756.5m
Cash & Short-Term Investments 119.4m
Receivables 196.8m
Other Current Assets 440.3m
Non-Current Assets 654.4m
Long-Term Investments 28m
PP&E 578.4m
Intangibles 15m
Other Non-Current Assets 33m
Current Liabilities 385.3m
Accounts Payable 78.1m
Other Current Liabilities 307.2m
Non-Current Liabilities 526.7m
Long-Term Debt 429.7m
Other Non-Current Liabilities 97m
Efficiency

Earnings Waterfall
Biotest AG

Revenue
684.6m EUR
Cost of Revenue
-404.3m EUR
Gross Profit
280.3m EUR
Operating Expenses
-160m EUR
Operating Income
120.3m EUR
Other Expenses
6.7m EUR
Net Income
127m EUR

Free Cash Flow Analysis
Biotest AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BIO Profitability Score
Profitability Due Diligence

Biotest AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score

Biotest AG's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

BIO Solvency Score
Solvency Due Diligence

Biotest AG's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
44/100
Solvency
Score

Biotest AG's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIO Price Targets Summary
Biotest AG

Wall Street analysts forecast BIO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO is 33.8 EUR .

Lowest
Price Target
Not Available
Average
Price Target
33.8 EUR
19% Downside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BIO Price
Biotest AG

1M 1M
-2%
6M 6M
-3%
1Y 1Y
+0%
3Y 3Y
+46%
5Y 5Y
+69%
10Y 10Y
-53%
Annual Price Range
41.6
52w Low
41.6
52w High
43.4
Price Metrics
Average Annual Return 19.37%
Standard Deviation of Annual Returns 36.99%
Max Drawdown -30%
Shares Statistics
Market Capitalization 1.6B EUR
Shares Outstanding 38 461 500
Percentage of Shares Shorted
N/A

BIO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biotest AG Logo
Biotest AG

Country

Germany

Industry

Biotechnology

Market Cap

1.6B EUR

Dividend Yield

0%

Description

Biotest AG is a DE-based company operating in Biotechnology industry. The company is headquartered in Dreieich, Hessen and currently employs 1,967 full-time employees. Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.

Contact

HESSEN
Dreieich
Landsteinerstr. 5
+4961038010.0
https://www.biotest.com/

IPO

1987-10-14

Employees

1 967

Officers

Chairman of the Board of Management
Mr. Peter Janssen
Chief Scientific Officer & Member of the Management Board
Dr. Jorg Schuttrumpf
Member of Supervisory Board
Dirk Schuck
Member of Management Board & CFO
Ms. Ainhoa Mendizabal Zubiaga
Head of Investor Relations
Dr. Monika Buttkereit
Head of Corporate HR
Dr. Christina Erb

See Also

Discover More
What is the Intrinsic Value of one BIO stock?

The intrinsic value of one BIO stock under the Base Case scenario is 36.5 EUR.

Is BIO stock undervalued or overvalued?

Compared to the current market price of 41.6 EUR, Biotest AG is Overvalued by 12%.